TAIJI GROUP(SH:600129)2023-10-26 16:00Financial Performance - The company's operating revenue for Q3 2023 was approximately ¥3.13 billion, a decrease of 7.43% compared to ¥3.36 billion in the same period last year[3]. - Net profit attributable to shareholders for Q3 2023 was approximately ¥192.75 million, an increase of 51.86% from ¥124.82 million year-on-year[3]. - Basic earnings per share for Q3 2023 were ¥0.35, representing a 52.17% increase compared to ¥0.22 in the same period last year[3]. - Total operating revenue for the first three quarters of 2023 reached ¥12,182,741,633.45, an increase of 14.6% compared to ¥10,632,713,868.26 in the same period of 2022[15]. - Total operating costs for Q3 2023 were ¥11,311,905,251.05, up 11.1% from ¥10,175,711,599.60 in Q3 2022[16]. - Net profit for Q3 2023 was ¥767,236,035.11, a significant increase from ¥250,316,665.75 in Q3 2022, representing a growth of 206.5%[17]. - The company reported a total profit of ¥911,550,395.40 for Q3 2023, compared to ¥331,775,466.67 in Q3 2022, marking a growth of 174.5%[17]. - The company’s total comprehensive income for Q3 2023 was ¥767,217,994.38, up from ¥250,222,523.43 in Q3 2022, indicating strong overall performance[18]. Assets and Liabilities - The total assets at the end of Q3 2023 were approximately ¥14.28 billion, a decrease of 4.12% from the previous year's end[3]. - As of September 30, 2023, the company's total assets amounted to RMB 14,281,965,839.55, a decrease from RMB 14,896,326,064.64 at the end of 2022, reflecting a decline of approximately 4.1%[13]. - The company's current assets totaled RMB 7,525,142,538.43, down from RMB 8,339,052,767.30 at the end of 2022, indicating a decrease of about 9.8%[11]. - The company's total liabilities decreased from RMB 11,969,326,021.98 to RMB 10,588,495,764.65, a reduction of approximately 11.5%[14]. - The equity attributable to shareholders increased from RMB 3,056,913,540.43 to RMB 3,813,253,290.13, reflecting a growth of about 24.7%[14]. Cash Flow - The company reported a net cash flow from operating activities of approximately -¥476.43 million for the year-to-date, indicating a significant decline compared to the previous year[6]. - The net cash flow from operating activities was -476,432,961.78, a decrease from 439,109,209.84 in the previous year[20]. - Total cash outflow from operating activities reached 12,036,444,284.05, compared to 9,937,221,772.20 in the same period last year[20]. - Cash inflow from operating activities for the first three quarters of 2023 was ¥11,560,011,322.27, an increase from ¥10,376,330,982.04 in the same period of 2022[19]. - Cash inflow from investment activities was 155,954,086.28, an increase from 89,544,473.47 year-over-year[20]. - The net cash flow from investment activities was -374,843,495.53, worsening from -290,326,047.29 in the previous year[20]. - Cash inflow from financing activities totaled 2,908,966,482.64, up from 2,645,178,383.12 in the same quarter last year[20]. - The net cash flow from financing activities was -356,363,539.23, an improvement from -418,627,817.15 year-over-year[20]. - The ending balance of cash and cash equivalents was 764,387,796.23, compared to 665,498,359.31 at the end of the previous year[20]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,241, with the largest shareholder holding 27.62% of the shares[7]. Research and Development - Research and development expenses for Q3 2023 amounted to ¥148,932,719.38, nearly doubling from ¥78,801,189.29 in Q3 2022, indicating a focus on innovation[16]. Other Financial Metrics - The return on equity for Q3 2023 was 5.19%, an increase of 0.90 percentage points from 4.29% in the same period last year[3]. - Non-recurring gains and losses for Q3 2023 totaled approximately ¥49.37 million, an increase from ¥42.97 million year-to-date[5]. - The company’s net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date increased by 121.76% compared to the previous year[5]. - The company experienced a decrease in investment income, reporting a loss of ¥3,976,453.58 in Q3 2023 compared to a gain of ¥6,026,467.23 in Q3 2022[16]. - Tax expenses for Q3 2023 were ¥144,314,360.29, an increase from ¥81,458,800.92 in Q3 2022, reflecting higher profitability[17]. - The company paid 1,492,356,145.59 in cash to employees, an increase from 1,284,118,503.53 in the previous year[20]. - The total cash paid for taxes was 1,228,179,722.85, up from 927,825,417.50 year-over-year[20]. - The company reported a cash outflow of 3,698,412,391.07 related to other operating activities, compared to 3,513,209,030.77 in the previous year[20]. Mergers and Acquisitions - The company has completed mergers with three subsidiaries, including Chongqing Traditional Chinese Medicine Co., Ltd., impacting financial statements[4]. Inventory and Receivables - Cash and cash equivalents decreased significantly from RMB 2,374,432,028.57 to RMB 1,015,853,772.23, representing a decline of approximately 57.3%[11]. - Accounts receivable increased from RMB 2,001,104,912.10 to RMB 2,705,002,608.33, marking an increase of about 35.1%[11]. - The company reported a significant increase in inventory from RMB 2,251,653,745.50 to RMB 2,697,592,340.43, which is an increase of approximately 19.7%[11]. - The company has ongoing investments in construction projects, with "in-progress construction" rising from RMB 740,808,027.69 to RMB 1,034,835,654.31, an increase of approximately 39.7%[13]. Product Development - The company has not reported any significant new product launches or technological advancements during this quarter[9].